BioAge Labs, Inc (BIOA) Stock Analysis

BioAge Labs, Inc (BIOA) is a publicly traded company in the HEALTHCARE sector. It trades at $16.54, carries a market capitalization of $764.59M. This page summarizes the public market data, fundamentals, and frequently asked questions for BIOA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

BioAge Labs, Inc currently has a Bullish sentiment score of 0.36.

About BioAge Labs, Inc

BioAge Labs, Inc. is a forward-thinking biotechnology company based in Montreal, Canada, dedicated to advancing healthspan and longevity through groundbreaking aging research. By leveraging insights from the biology of aging, BioAge focuses on the discovery and validation of therapeutics targeting age-related diseases, positioning itself as a leader in the transformative landscape of geriatric healthcare. With a commitment to scientific excellence and collaboration with premier research insti...

GNG Research Analysis

GNG Research scores BioAge Labs, Inc (BIOA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BIOA.

Frequently Asked Questions

Does BIOA pay dividends?

BioAge Labs, Inc (BIOA) does not currently pay a regular dividend.

What is BIOA's market cap?

BioAge Labs, Inc (BIOA) has a market capitalization of $764.59M with a current stock price of $16.54.